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Inflammation (derived from the Latin
inflammo, which means ‘‘I set alight’’) is a
beneficial response of our immune system
that protects us against infection and tissue
injury. Like all immune responses, it needs
to be tightly controlled: excessive inflam-
matory responses can lead to both acute
diseases, such as septic shock, and chronic
diseases, such as rheumatoid arthritis,
atherosclerosis, and cancer. Until recently,
it was thought that the negative regulatory
loops that kick in early to counteract
inflammation were mainly a result of
changes in mRNA levels either through
transcriptional activation of inhibitory
proteins or posttranscriptional repression
of proinflammatory molecules by RNA-
binding proteins (RBP) or microRNAs. A
paper by Georg Stoecklin and colleagues
at the German Cancer Research Center
now challenges this notion by demonstrat-
ing that, in the early stages of macrophage
activation, translational derepression is a
major mechanism that induces feedback
inhibitors to dampen inflammation [1].
Although neutrophils are the first cells
that localise to sites of tissue injury or
infection, it is macrophages that orches-
trate the multiple components of the
inflammatory response through their abil-
ity to sense microbial products such as
lipopolysaccharides (LPS), which bind toll-
like receptor 4 (TLR4). TLR4 ligation
initiates a signalling cascade in macro-
phages that leads to the production of
proinflammatory molecules, of which tu-
mor necrosis factor (TNF) is one of the
most important [2]. TLR4 signalling and
TNF signalling activate several transcrip-
tion factors, most prominently NF-kB
(nuclear factor k-light-chain-enhancer of
activated B cells), that are important for
the elimination of pathogens, irritants, or
dead cells. Equally important for the
healing of tissues later in the inflammatory
response is the production of negative
regulators of the NF-kB pathway and
other inflammatory pathways, which limit
the amount of inflammatory mediators
and curtail the response in a timely
manner [3].
Over the last few years, a number of
studies have investigated global gene
activation induced by pathogen-derived
stimuli to gain insights into the modes of
induction of the inflammatory mediators
and regulators. Studies focusing on the
early stages of inflammation only assessed
changes in mRNA levels [4] and identified
the importance of mRNA stability in the
temporal control of inflammatory mole-
cules. Parallel studies that specifically
interrogated translational changes only
looked at later stages of the response and
were performed in cells other than mac-
rophages [5,6]. Of note, these latter
studies reported translational inhibition
of ribosomal proteins and RNAs encoding
chemoattractants and their receptors. The
present study by Schott et al. [1] is the first
to investigate translational regulation in
the early phase of macrophage activation
and to identify translational derepression
as an important mechanism underpinning
negative feedback of the inflammatory
response.
In assessing translation, sucrose density
gradient centrifugation of cell extracts is
often used to separate cellular mRNAs by
their association with ribosomes. In com-
bination with microarray analysis, this
approach is known as translation state
array analysis (TSAA). TSAA measures
the proportion of mRNAs in dense
polysomal complexes as an indicator of
their translational activity [7]. The inves-
tigators treated cultures of the murine
RAW264.7 macrophage cell line with
LPS for 1 h and performed TSAA, in
addition to measuring mRNA steady-state
levels in parallel by RNA-seq. This
combination allowed them to focus on
mRNAs with an active change in ribo-
some load, identifying 59 cases of trans-
lational up-regulation and 55 cases of
down-regulation, many of which could be
validated by quantitative polymerase
chain reaction (qPCR) not only in the
original cell line but also in primary
cultured macrophages. Four cytokine
mRNAs scored as up-regulated (Tnf,
Cxcl2, Il23a, and Tnfsf9) while, surpris-
ingly, several mRNAs encoding proteins
classed as feedback inhibitors of TLR4
signalling were also actively derepressed
in their translation (Figure 1). Among the
latter were those encoding likely inhibi-
tors of NF-kB activation (IkBd, IER3,
and NR4A1), the p38 mitogen-activated
protein kinase (MAPK) pathway inhibitor
dual specificity phosphatase 1 (DUSP1),
as well as the RBPs ZFP36 and
ZC3H12A, known inhibitors of cytokine
expression. Most cytokine mRNAs were
scarce in resting macrophages and strong-
ly induced. By contrast, feedback inhibi-
tor mRNAs tended to already be abun-
dant and showed relatively modest
increases in steady-state level upon acti-
vation.
A motif search by Schott et al. [1]
identified an overrepresentation of the
adenylate-uridylate-rich element (AU-rich
element; ARE) within the 39 untranslated
regions (UTRs) of translationally up-regu-
lated mRNAs. AREs are present in the 39
UTR of many cytokine mRNAs, including
the Tnf mRNA, and recruit a range of
RBPs to regulate mRNA stability and
translation [8]. The authors further inves-
tigated the example of IER3 mRNA 39
UTR to show that the ARE element was
required for repression in resting cells as
well as derepression after LPS induction.
The present study makes no further inroads
into identifying the molecular players
and mechanism involved in this ARE-
mediated repression/derepression. One
intriguing possibility we see is that it could
be driven by a switch to aerobic glycolysis
commonly seen in activated immune cells
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[9] and involve ARE-binding by the
glycolysis enzyme glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), as reported for
interferon c (IFNc) mRNA during T cell
activation [10]. Binding of metabolic
enzymes to RNA has been repeatedly
reported and might underpin a broader
crosstalk between metabolism and gene
regulation and offer novel therapeutic
possibilities [11].
The corollary from the studies by
Schott et al. [1] is that, upon macrophage
activation, expression of several anti-
inflammatory inhibitors is driven by
translational up-regulation of preexisting
mRNAs. That cells choose the relatively
resource-costly approach of stockpiling
these mRNAs highlights their need to
swiftly mount a feedback response to
contain the inflammatory response. By
contrast, induction of proinflammatory
cytokines is predominately achieved by
changes in mRNA abundance. This adds
a new facet to the multilevel gene
regulatory network controlling the inflam-
matory response. While we have known
about the post-transcriptional regulation
of cytokine mRNAs for some time, there
is now a need to better understand how
cells ensure the swift production of
feedback inhibitors using translational
control.
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Figure 1. Different modes of mRNA regulation in inflammation. Diagram representing
differential control of feedback inhibitor mRNAs and cytokine mRNAs in resting versus activated
macrophages. In the resting state, feedback inhibitor mRNAs are being transcribed but
translationally repressed; they become derepressed in the early phase of activation. By contrast,
most cytokine mRNAs, which are generally unstable, are not expressed in resting macrophages,
and their steady-state levels increase quickly upon activation.
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